Minimal	0	7	O
contribution	8	20	O
of	21	23	O
marrow	24	30	B-Cell
-	30	31	I-Cell
derived	31	38	I-Cell
endothelial	39	50	I-Cell
precursors	51	61	I-Cell
to	62	64	O
tumor	65	70	B-Multi-tissue_structure
vasculature	71	82	I-Multi-tissue_structure
.	82	83	O

During	85	91	O
embryogenesis	92	105	O
,	105	106	O
vascular	107	115	B-Cell
and	116	119	O
hemopoietic	120	131	B-Cell
cells	132	137	I-Cell
originate	138	147	O
from	148	152	O
a	153	154	O
common	155	161	O
precursor	162	171	O
,	171	172	O
the	173	176	O
hemangioblast	177	190	B-Cell
.	190	191	O

Recent	192	198	O
evidence	199	207	O
suggests	208	216	O
the	217	220	O
existence	221	230	O
of	231	233	O
endothelial	234	245	B-Cell
precursors	246	256	I-Cell
in	257	259	O
adult	260	265	O
bone	266	270	B-Cell
marrow	271	277	I-Cell
cells	278	283	I-Cell
,	283	284	O
but	285	288	O
it	289	291	O
is	292	294	O
unclear	295	302	O
whether	303	310	O
those	311	316	O
precursors	317	327	O
have	328	332	O
a	333	334	O
role	335	339	O
in	340	342	O
tumor	343	348	B-Pathological_formation
neovascularization	349	367	O
.	367	368	O

In	369	371	O
this	372	376	O
report	377	383	O
,	383	384	O
we	385	387	O
demonstrate	388	399	O
that	400	404	O
murine	405	411	B-Organism
bone	412	416	B-Multi-tissue_structure
marrow	417	423	I-Multi-tissue_structure
contains	424	432	O
endothelial	433	444	B-Cell
progenitors	445	456	I-Cell
,	456	457	O
which	458	463	O
arise	464	469	O
from	470	474	O
a	475	476	O
cell	477	481	B-Cell
with	482	486	O
self	487	491	O
-	491	492	O
renewing	492	500	O
capacity	501	509	O
,	509	510	O
and	511	514	O
can	515	518	O
integrate	519	528	O
into	529	533	O
tumor	534	539	B-Tissue
microvasculature	540	556	I-Tissue
,	556	557	O
albeit	558	564	O
at	565	567	O
a	568	569	O
very	570	574	O
low	575	578	O
frequency	579	588	O
.	588	589	O

A	590	591	O
transgenic	592	602	O
double	603	609	O
-	609	610	O
reporter	610	618	O
strategy	619	627	O
allowed	628	635	O
us	636	638	O
to	639	641	O
demonstrate	642	653	O
definitively	654	666	O
that	667	671	O
tumor	672	677	B-Cell
bone	678	682	I-Cell
marrow	683	689	I-Cell
-	689	690	I-Cell
derived	690	697	I-Cell
endothelial	698	709	I-Cell
cells	710	715	I-Cell
arise	716	721	O
by	722	724	O
transdifferentiation	725	745	O
of	746	748	O
marrow	749	755	B-Cell
progenitors	756	767	I-Cell
rather	768	774	O
than	775	779	O
by	780	782	O
cell	783	787	B-Cell
fusion	788	794	O
.	794	795	O

Single	796	802	O
cell	803	807	B-Cell
transplants	808	819	O
showed	820	826	O
that	827	831	O
a	832	833	O
common	834	840	O
precursor	841	850	O
contributes	851	862	O
to	863	865	O
both	866	870	O
the	871	874	O
hemopoietic	875	886	B-Cell
and	887	890	O
endothelial	891	902	B-Cell
lineages	903	911	I-Cell
,	911	912	O
thus	913	917	O
demonstrating	918	931	O
the	932	935	O
presence	936	944	O
of	945	947	O
an	948	950	O
adult	951	956	O
hemangioblast	957	970	B-Cell
.	970	971	O

Furthermore	972	983	O
,	983	984	O
we	985	987	O
demonstrate	988	999	O
that	1000	1004	O
increased	1005	1014	O
vascular	1015	1023	B-Gene_or_gene_product
endothelial	1024	1035	I-Gene_or_gene_product
growth	1036	1042	I-Gene_or_gene_product
factor	1043	1049	I-Gene_or_gene_product
(	1050	1051	I-Gene_or_gene_product
VEGF	1051	1055	I-Gene_or_gene_product
)	1055	1056	I-Gene_or_gene_product
-	1056	1057	I-Gene_or_gene_product
A	1057	1058	I-Gene_or_gene_product
secretion	1059	1068	O
by	1069	1071	O
tumor	1072	1077	B-Cell
cells	1078	1083	I-Cell
,	1083	1084	O
as	1085	1087	O
well	1088	1092	O
as	1093	1095	O
activation	1096	1106	O
of	1107	1109	O
VEGF	1110	1114	B-Gene_or_gene_product
receptor	1115	1123	I-Gene_or_gene_product
-	1123	1124	I-Gene_or_gene_product
2	1124	1125	I-Gene_or_gene_product
in	1126	1128	O
bone	1129	1133	B-Cell
marrow	1134	1140	I-Cell
cells	1141	1146	I-Cell
does	1147	1151	O
not	1152	1155	O
alter	1156	1161	O
the	1162	1165	O
mobilization	1166	1178	O
and	1179	1182	O
incorporation	1183	1196	O
of	1197	1199	O
marrow	1200	1206	B-Cell
-	1206	1207	I-Cell
derived	1207	1214	I-Cell
endothelial	1215	1226	I-Cell
progenitors	1227	1238	I-Cell
into	1239	1243	O
tumor	1244	1249	B-Tissue
vasculature	1250	1261	I-Tissue
.	1261	1262	O

Finally	1263	1270	O
,	1270	1271	O
in	1272	1274	O
human	1275	1280	B-Organism
umbilical	1281	1290	B-Cell
cord	1291	1295	I-Cell
blood	1296	1301	I-Cell
cells	1302	1307	I-Cell
,	1307	1308	O
we	1309	1311	O
show	1312	1316	O
that	1317	1321	O
endothelial	1322	1333	B-Cell
precursors	1334	1344	I-Cell
make	1345	1349	O
up	1350	1352	O
only	1353	1357	O
approximately	1358	1371	O
1	1372	1373	O
in	1374	1376	O
10	1377	1379	O
(	1379	1380	O
7	1380	1381	O
)	1381	1382	O
mononuclear	1383	1394	B-Cell
cells	1395	1400	I-Cell
but	1401	1404	O
are	1405	1408	O
highly	1409	1415	O
enriched	1416	1424	O
in	1425	1427	O
the	1428	1431	O
CD133	1432	1437	B-Gene_or_gene_product
+	1437	1438	O
cell	1439	1443	O
population	1444	1454	O
.	1454	1455	O

By	1456	1458	O
ruling	1459	1465	O
out	1466	1469	O
cell	1470	1474	B-Cell
fusion	1475	1481	O
,	1481	1482	O
we	1483	1485	O
clearly	1486	1493	O
demonstrate	1494	1505	O
the	1506	1509	O
existence	1510	1519	O
of	1520	1522	O
an	1523	1525	O
adult	1526	1531	O
hemangioblast	1532	1545	B-Cell
,	1545	1546	O
but	1547	1550	O
the	1551	1554	O
differentiation	1555	1570	O
of	1571	1573	O
marrow	1574	1580	B-Cell
stem	1581	1585	I-Cell
cells	1586	1591	I-Cell
toward	1592	1598	O
the	1599	1602	O
endothelial	1603	1614	B-Cell
lineage	1615	1622	I-Cell
is	1623	1625	O
an	1626	1628	O
extremely	1629	1638	O
rare	1639	1643	O
event	1644	1649	O
.	1649	1650	O

Furthermore	1651	1662	O
,	1662	1663	O
we	1664	1666	O
show	1667	1671	O
that	1672	1676	O
VEGF	1677	1681	B-Gene_or_gene_product
-	1681	1682	I-Gene_or_gene_product
A	1682	1683	I-Gene_or_gene_product
stimulation	1684	1695	O
of	1696	1698	O
hemopoietic	1699	1710	B-Cell
cells	1711	1716	I-Cell
does	1717	1721	O
not	1722	1725	O
significantly	1726	1739	O
alter	1740	1745	O
this	1746	1750	O
process	1751	1758	O
.	1758	1759	O

